How endobronchial valves change oxygen use during everyday activities
Official title: Change in Task-related Oxygen Uptake After Bronchoscopic Lung Volume Reduction With Endobronchial Valves
Run by University Medical Center Groningen · NCT06702072 · Data updated 2026-11-12
This will see if endobronchial valve treatment helps people with severe emphysema use less oxygen and feel less breathless when doing daily tasks.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University Medical Center Groningen Academic / other |
| Locations | 1 site (Groningen) |
| Status | Recruiting |
| Started | June 2, 2025 |
| Main results expected | August 1, 2028 |
| Study ends | August 1, 2028 |
| Registry record updated | April 29, 2026 |
| Trial ID | NCT06702072 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with severe emphysema who are scheduled for Pulmonx Zephyr endobronchial valve placement, can perform ADLs without long-term oxygen therapy, and can give informed consent.
✕Probably not a fit
Patients who require long-term oxygen therapy during ADLs or who are not eligible for EBV placement are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study of patients scheduled for bronchoscopic lung volume reduction with Pulmonx Zephyr endobronchial valves. Researchers will measure oxygen uptake (VO2) and carbon dioxide production (VCO2) with a portable metabolic device while participants perform typical activities of daily living before and after EBV treatment. The primary focus is to compare the metabolic load and symptom perception during ADLs rather than laboratory walk tests. Results will show whether physiological effort during real-world tasks changes after valve placement.
Why it matters
Potential benefit: If successful, the treatment could reduce metabolic load and breathlessness during daily activities, making routine tasks easier for patients.
How similar studies have gone: Previous EBV research has shown improvements in exercise capacity by 6-minute walk tests and patient reports of easier ADLs, but the metabolic load during real-world ADLs has not been measured before.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient is scheduled for a bronchoscopic lung volume treatment using Pulmonx Zephyr Endobronchial Valves; 2. Patient read, understood and signed the Informed Consent Form. Exclusion Criteria: 1\) Patients who cannot perform ADL activities without the use of Long Term Oxygen Therapy (LTOT).
Where it's running
-
University Medical Center Groningen
Groningen, Netherlands Recruiting
Study contacts
- Principal investigator: Dirk-Jan Slebos, MD PHD — University Medical Center Groningen
- Study coordinator: Jorine E Hartman, PhD
- Email: j.hartman@umcg.nl
- Phone: 0031503619194
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
-
Biomarker clues for COPD, IPF, and lung cancer
This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.
-
HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults
This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.